Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 407,300 | 37,000 | 21,100 | -142,542 | -141,090 |
| Depreciation Amortization | 30,000 | 27,700 | 22,900 | 15,941 | 4,973 |
| Income taxes - deferred | -310,700 | N/A | N/A | N/A | N/A |
| Accounts receivable | -30,500 | -69,200 | -25,100 | -31,127 | N/A |
| Other Working Capital | -37,900 | -4,800 | -1,700 | -8,807 | 5,781 |
| Other Operating Activity | 170,300 | 156,300 | 84,200 | 72,204 | 24,155 |
| Operating Cash Flow | $228,500 | $147,000 | $101,400 | $-94,331 | $-106,181 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -735,500 | -196,400 | -218,100 | -244,320 | 117,050 |
| PPE Investments | -10,900 | -14,700 | -24,800 | -6,933 | -4,095 |
| Sale Of Investment | 750,500 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $4,100 | $-211,100 | $-242,900 | $-251,253 | $112,955 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -186,900 | N/A | N/A | 502,781 | N/A |
| Common Stock Issued | 29,100 | 32,400 | 29,500 | 13,865 | 2,390 |
| Financing Cash Flow | $-157,800 | $32,400 | $29,500 | $516,646 | $2,390 |
| Beginning Cash Position | 115,500 | 147,200 | 259,200 | 88,150 | 78,986 |
| End Cash Position | 190,300 | 115,500 | 147,200 | 259,212 | 88,150 |
| Net Cash Flow | $74,800 | $-31,700 | $-112,000 | $171,062 | $9,164 |
| Free Cash Flow | |||||
| Operating Cash Flow | 228,500 | 147,000 | 101,400 | -94,331 | -106,181 |
| Capital Expenditure | -10,900 | -14,700 | -24,800 | -6,940 | -4,108 |
| Free Cash Flow | 217,600 | 132,300 | 76,600 | -101,271 | -110,289 |